Cargando…
Real-World Cost-Effectiveness Analysis: How Much Uncertainty Is in the Results?
Cost-effectiveness analyses of new cancer treatments in real-world settings (e.g., post-clinical trials) inform healthcare decision makers about their healthcare investments for patient populations. The results of these analyses are often, though not always, presented with statistical uncertainty. T...
Autores principales: | Barr, Heather K., Guggenbickler, Andrea M., Hoch, Jeffrey S., Dewa, Carolyn S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136635/ https://www.ncbi.nlm.nih.gov/pubmed/37185423 http://dx.doi.org/10.3390/curroncol30040310 |
Ejemplares similares
-
Rapid Review of Real-World Cost-Effectiveness Analyses of Cancer Interventions in Canada
por: Guggenbickler, Andrea M., et al.
Publicado: (2022) -
Lessons from Cost-Effectiveness Analysis of Smoking Cessation Programs for Cancer Patients
por: Hoch, Jeffrey S., et al.
Publicado: (2022) -
Building a public health workforce for a university campus during a pandemic using a practicum framework: Design and outcomes
por: Dewa, Carolyn S., et al.
Publicado: (2022) -
Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians
por: Hoch, Jeffrey S., et al.
Publicado: (2022) -
How Much Does That Treatment Cost?
por: Viale, Pamela Hallquist
Publicado: (2013)